- Home
- HLI vs ASND Comparison
HLI vs ASND Comparison
Compare HLI & ASND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HLI
- ASND
- Stock Information
- Founded
- HLI 1972
- ASND 2006
- Country
- HLI United States
- ASND Denmark
- Employees
- HLI N/A
- ASND N/A
- Industry
- HLI Investment Managers
- ASND Biotechnology: Pharmaceutical Preparations
- Sector
- HLI Finance
- ASND Health Care
- Exchange
- HLI Nasdaq
- ASND Nasdaq
- Market Cap
- HLI 12.8B
- ASND 10.6B
- IPO Year
- HLI 2015
- ASND 2015
- Fundamental
- Price
- HLI $185.51
- ASND $174.18
- Analyst Decision
- HLI Buy
- ASND Strong Buy
- Analyst Count
- HLI 7
- ASND 17
- Target Price
- HLI $193.67
- ASND $220.06
- AVG Volume (30 Days)
- HLI 383.9K
- ASND 399.8K
- Earning Date
- HLI 07-29-2025
- ASND 09-02-2025
- Dividend Yield
- HLI 1.29%
- ASND N/A
- EPS Growth
- HLI 41.61
- ASND N/A
- EPS
- HLI 5.82
- ASND N/A
- Revenue
- HLI $2,389,126,000.00
- ASND $398,509,511.00
- Revenue This Year
- HLI $10.96
- ASND $75.05
- Revenue Next Year
- HLI $11.58
- ASND $78.14
- P/E Ratio
- HLI $31.87
- ASND N/A
- Revenue Growth
- HLI 24.80
- ASND 12.06
- 52 Week Low
- HLI $133.48
- ASND $111.09
- 52 Week High
- HLI $192.10
- ASND $183.00
- Technical
- Relative Strength Index (RSI)
- HLI 68.30
- ASND 55.04
- Support Level
- HLI $176.75
- ASND $167.52
- Resistance Level
- HLI $185.40
- ASND $180.78
- Average True Range (ATR)
- HLI 3.21
- ASND 5.72
- MACD
- HLI 0.68
- ASND -0.62
- Stochastic Oscillator
- HLI 95.76
- ASND 52.65
About HLI Houlihan Lokey Inc.
Houlihan Lokey Inc is an investment bank with expertise in mergers and acquisitions, capital markets, financial restructuring, valuation, and strategic consulting. The firm serves corporations, institutions, and governments world-wide with offices in the United States, Europe, and the Asia-Pacific region. The company operates in three segments. In the Corporate Finance business segment, it provides M&A and capital markets advisory services. Through the Financial Restructuring business segment, the company advises on some of the complex restructurings around the world. The Financial and Valuation Advisory Services business segment provides valuation and financial opinion, and financial and strategic consulting practices in the United States.
About ASND Ascendis Pharma A/S
Ascendis Pharma AS is a biopharmaceutical company that applies its TransCon technology platform to make a meaningful difference for patients. The firm's product pipeline includes Endocrinology and Oncology which includes TransCon PTH, TransCon CNP, and others. It operates in North America, Europe, and Rest of the world and derives the majority of its revenue from North America.